Author:
Takanashi Satoshi,Nakazato Tomonori,Aisa Yoshinobu,Ito Chisako,Arakaki Hideki,Osada Yuki,Hirano Motoharu,Mori Takehiko
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference29 articles.
1. Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundström C (2008) Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 350–351
2. Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100–1104
3. Ellman MH, Hurwitz H, Thomas C, Kozloff M (1991) Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18:1741–1743
4. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943–1949
5. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99:3909–3915
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献